Do you want to read an article? Please log in or register.
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis
Systemic Sclerosis
Related content
Systemic Sclerosis
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity
Rheumatology (Oxford).
Zheng B, Nevskaya T, Baxter CA, Ramey DR, Pope JE, Baron M, Canadian Scleroderma Research Group .
doi: 10.1093/rheumatology/kez299.
Systemic Sclerosis
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Ann Rheum Dis.
Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, Hant FN, Gordon JK, Shah AA, Zhu L, Zheng WJ, Browning JL, Barron AMS, Wu M, Visvanathan S, Baum P, Franks JM, Whitfield ML, Shanmugam VK, Domsic RT, Castelino FV, Bernstein EJ, Wareing N, Lyons MA, Ying J, Charles J, Mayes MD, Assassi S
doi: 10.1136/annrheumdis-2019-215894.
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Ann Rheum Dis.
Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP
doi: 10.1136/
Systemic Sclerosis
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
Ann Rheum Dis.
Khanna D, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, de Oliveira Pena J, Yao Z, Kramer F, Distler O
doi: 10.1136/annrheumdis-2019-216823.
Systemic Sclerosis
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort
Swiss Med Wkly
Hernández J, Jordan S, Dobrota R, Iudici M, Hasler P, Ribi C, Villiger P, Vlachoyiannopoulos P, Vacca A, Garzanova L, Giollo A, Rosato E, Kötter I, Carreira PE, Doria A, Henes J, Müller-Ladner U, Smith V, Distler J, Gabrielli A, Hoffman-Vold AM, Walker U, Distler O, The Eustar Collaborators
doi: 10.4414/smw.2021.20528
Systemic Sclerosis
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
Arthritis Res Ther
Farutin V, Kurtagic E, Pradines JR, Capila I, Mayes MD, Wu M, Manning AM, Assassi S
doi: 10.1186/s13075-021-02633-5
Systemic Sclerosis
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
Ann Rheum Dis.
Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, Matucci-Cerinic M, de Oliveira Pena J, Pope JE, Distler O, EUSTAR Collaborators., EUSTAR Collaborators (numerical order of centres).
doi: 10.1136/annrheumdis-
Atopic Dermatitis
Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients
J Allergy Clin Immunol.
Guttman-Yassky E, Bissonnette R, Ungar B, Suárez-Fariñas M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NMH, Pirozzi G, Yancopoulos GD, Hamilton JDD
doi: 10.1016/j.jaci.2018.08.022.
COMMENTED
Systemic Sclerosis
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
★ 3
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
Arthritis Res Ther.
Pan Z, Marra AM, Benjamin N, Eichstaedt CA, Blank N, Bossone E, Cittadini A, Coghlan G, Denton CP, Distler O, Egenlauf B, Fischer C, Harutyunova S, Xanthouli P, Lorenz HM, Grünig E
doi: 10.1186/s13075-019-1981-0.